JPRN-UMIN000031095
Completed
未知
sefulness of FDG-PET/CT examination as prediction of effect of immune checkpoint inhibitors in patients with non-small cell lung cancer : a pilot study - Usefulness of FDG-PET/CT as prediction of effect of immune checkpoint inhibitors in lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- advanced and recurrent non-small cell lung cancer
- Sponsor
- Kansai Medical University
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with serious liver dysfunction or renal dysfunction 2\)Pregnant or lactating females 3\)Patients with clinically significant psychiatric disease that would interfere with participation in this study 4\)Patients with history of previous immune checkpoint inhibitor treatment 5\)Patients with history of autoimmune diseases 6\)Patients with serious interstitial lung disease or infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
Recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancerPreviously treated advanced non-small cell lung cancerJPRN-UMIN000020814Gunma30
Unknown
Not Applicable
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
Active, not recruiting
Not Applicable
se of the PET-Scan examination in the evaluation of the treatment of patients diagnosed with Head and Neck CancerScamous Cell- Carcinoma of Head and NeckNeoplasmsPositron Emission Tomography Computed TomographyC04.557.470.200.400E01.370.350.350.800.700.500RBR-9wwstdAC Camargo Cancer Center
Recruiting
Phase 1
FDG-PET study for pulmonary MAC and CPAJPRN-jRCTs071190035Takazono Takahiro15